Veterans’ RightsAn independent resource for veterans
← All decisions
Denied

The Board has denied a rating in excess of 10 percent for Pseudofolliculitis Barbae (PFB) from July 18, 2010 due to the Veteran's symptoms not meeting the criteria for a higher rating under the current VA rating schedule.

The deciding factor: The Veteran's PFB manifests with no more than topical therapy required over the past 12-month period and characteristic lesions involving less than 5 percent of the exposed area and entire body affected, which corresponds to a noncompensable evaluation under the new criteria.

Claimed conditions
Pseudofolliculitis Barbae (PFB)
How they argued it
Direct service connection
Exposure basis
None
Rating assigned
10%
Decision date
February 1, 2023
Citation
23006440

This is a plain-language summary generated by AI from a public Board of Veterans’ Appeals decision. It can contain errors — always verify against the original. Look up the original decision on VA.gov (opens in a new tab) using citation 23006440.

What this means for you

A denial is a starting point, not the end of the road. You can see why this claim fell short — and, if you are still inside the one-year window, the appeal lanes that may remain open to you.

What you can do next

Related decisions

Other Board decisions on a similar condition or argued the same way.

Free starter guide for your own claim

Reading this because you were denied or under-rated? Get the plain-English next steps — your appeal options, the deadline that protects you, and how appeals like yours turn out. One email, no spam.

We will only use this to send the guide. No spam, unsubscribe any time. We never sell your information.

We are not the VA. Veterans’ Rights is an independent resource built for veterans. We are not the U.S. Department of Veterans Affairs, not part of the government, and not endorsed by any government agency.

This is general information, not legal advice. For advice about your own situation, talk to a VA-accredited representative — many help for free.